# Baseline Cortical Haemodynamics in MS

> **NCT02481882** · NA · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 80 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** Magnetic Resonance Imaging
- **DRUG:** Prohance (Gadoteridol)

## Key facts

- **NCT ID:** NCT02481882
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481882, "Baseline Cortical Haemodynamics in MS". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02481882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*